Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carla Masini
Observed names:
C Masini,
C. Masini,
Carla MASINI
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institutions:
Azienda Sanitaria Unità Locale di Reggio Emilia,
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori,
Santa Maria Nuova Hospital
ORCID:
0000-0002-8744-0708
Observed ORCID:
0000-0002-8744-0708
OpenAlex ID:
A5026657304
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
2015
·
S Salvi
, V Casadio
, et al.
·
British Journal of Cancer
·
134
PDF
Automated preparation of chemotherapy: Quality improvement and economic sustainability
2014
·
Carla Masini
, Oriana Nanni
, et al.
·
American Journal of Health-System Pharmacy
·
72
Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide
2014
·
Vincenza Conteduca
, Salvatore Luca Burgio
, et al.
·
The Prostate
·
60
Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo
2014
·
Rudolf Schierl
, Carla Masini
, et al.
·
Journal of Oncology Pharmacy Practice
·
53
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2
2020
·
O. Caffo
, V. Zagonel
, et al.
·
Annals of Oncology
·
35
PDF
Robotic i.v. medication compounding: Recommendations from the international community of APOTECAchemo users
2016
·
Angela W. Yaniv
, Adam Orsborn
, et al.
·
American Journal of Health-System Pharmacy
·
31
Production and Quality Control of [177Lu]Lu-PSMA-I&T: Development of an Investigational Medicinal Product Dossier for Clinical Trials
2022
·
Valentina Di Iorio
, Stefano Boschi
, et al.
·
Molecules
·
27
PDF
Development and validation of an HPLC-DAD method for the simultaneous identification and quantification of Topotecan, Irinotecan, Etoposide, Doxorubicin and Epirubicin
2020
·
Seydou Sanogo
, Paolo Silimbani
, et al.
·
Arabian Journal of Chemistry
·
22
PDF
The relative contribution of the decreasing trend in tumour thickness to the 2010s increase in net survival from cutaneous malignant melanoma in Italy: a population‐based investigation*
2022
·
Federica Zamagni
, Lauro Bucchi
, et al.
·
British Journal of Dermatology
·
21
PDF
Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients
2017
·
Alberto Farolfi
, Paolo Silimbani
, et al.
·
Oncotarget
·
21
PDF
Hydroxychloroquine as Prophylaxis for COVID-19: A Review
2020
·
Manuela Monti
, Bernadette Vertogen
, et al.
·
Frontiers in Pharmacology
·
18
PDF
The challenge of sustainability in healthcare systems: economic and organizational impact of subcutaneous formulations for rituximab and trastuzumab in onco-hematology
2020
·
Mattia Altini
, Nicola Gentili
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
17
CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia
2020
·
Alessandro Cafaro
, Maria B. Giannini
, et al.
·
Minerva Medica
·
14
Real-World Safety and Outcome of First-Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (“PEMBROREAL” Study)
2024
·
Alessandro Cafaro
, Flavia Foca
, et al.
·
Cancers
·
13
New-generation androgen receptor signaling inhibitors (ARSIs) in metastatic hormone-sensitive prostate cancer (mHSPC): pharmacokinetics, drug-drug interactions (DDIs), and clinical impact
2024
·
Lorenzo Gasperoni
, Emilio Francesco Giunta
, et al.
·
Expert Opinion on Drug Metabolism & Toxicology
·
12
PDF
The descriptive epidemiology of melanoma in Italy has changed - for the better
2023
·
Lauro BUCCHI
, the Italian Melanoma Intergroup and the AIRTUM Working Group
, et al.
·
Italian Journal of Dermatology and Venereology
·
12
Optimization of resources by drug management: A multicentred web-administered study on the use of ipilimumab in Italy
2018
·
V Damuzzo
, A Russi
, et al.
·
Journal of Oncology Pharmacy Practice
·
12
Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hope
2020
·
Delia Cangini
, Paolo Silimbani
, et al.
·
Minerva Medica
·
11
Pembrolizumab in a Patient With Heavily Pre-Treated Squamous Cell Thymic Carcinoma and Cardiac Impairment: A Case Report and Literature Review
2020
·
Alessandro Cafaro
, Alberto Bongiovanni
, et al.
·
Frontiers in Oncology
·
10
PDF
PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial
2020
·
Oriana Nanni
, Pierluigi Viale
, et al.
·
Trials
·
10
PDF
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)
2024
·
Alessandro Cafaro
, Flavia Foca
, et al.
·
Frontiers in Oncology
·
9
PDF
[18F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality Issue
2021
·
Valentina Di Iorio
, Stefano Boschi
, et al.
·
Pharmaceuticals
·
9
PDF
Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer
2018
·
Seydou Sanogo
, Paolo Silimbani
, et al.
·
European Journal of Hospital Pharmacy
·
9
Multicentric survey on dose reduction/interruption of cancer drug therapy in 12.472 patients: indicators of suspected adverse reactions
2016
·
Andrea Casadei Gardini
, Elena Tenti
, et al.
·
Oncotarget
·
9
PDF
The Challenge of Sustainability of High-Cost Oncological Drugs: A Budgeting Model in an Italian Cancer Center
2021
·
Carla Masini
, Davide Gallegati
, et al.
·
International Journal of Environmental Research and Public Health
·
8
PDF
Show more works
View as search
Works count:
55
Citation count:
710
H-index:
13
I10-index:
20
Year
Topic
Type